Research institution
University of Central Florida — Debopam Chakrabarti laboratory
DiscoverDevelop
Debopam Chakrabarti's laboratory discovers and optimizes antimalarial compounds, including natural-product and kinase-targeted approaches intended to work against drug-resistant parasites.
0
Endemic countries
1
U.S. states
2
Products and programs
About
What they do
Debopam Chakrabarti's laboratory discovers and optimizes antimalarial compounds, including natural-product and kinase-targeted approaches intended to work against drug-resistant parasites.1,2,3 Its U.S. R&D is based at the University of Central Florida in Orlando, Florida.1,3 The work spans the discovery and development stages, from screening natural-product libraries and repurposed kinase inhibitors through hit-to-lead optimization and testing in humanized mouse models.1,4,2,3
In the United States
- Orlando, FL1,3Research and development
Products and programs
In the field and in development
Where they work
Partnerships
No endemic-country partnerships are listed.
U.S. partners
Who they work with in the United States
- In the atlas
- In the atlas
Sources
Where this comes from
- 1med.ucf.edu
- 2mesamalaria.org
- 3Confirmed by the organization
- 4ucf.edu
- 5med.ucf.edu